Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
Dentsply Sirona Inc. (Nasdaq: XRAY), a global innovator in dental technologies and oral health solutions, provides this dedicated news hub for stakeholders tracking its market activities. Access real-time updates on earnings reports, product launches, regulatory milestones, and strategic partnerships shaping the dental industry.
This resource consolidates official press releases and verified news to help investors and professionals stay informed about XRAY developments. Key updates include innovations in CAD/CAM systems, digital imaging advancements, and global distribution initiatives.
Bookmark this page for streamlined access to critical updates impacting dental practices and investment decisions. Regular visitors gain timely insights into how Dentsply Sirona maintains its leadership through technological excellence and operational execution.
Dentsply Sirona, the world's largest manufacturer of professional dental products and technologies, has published its 2023 Sustainability Report. The report showcases strong progress in the company's sustainability strategy 'BEYOND: Taking Action for a Brighter World', with several goals achieved ahead of the 2025 timeframe.
Key highlights include:
- 47% reduction in Scope 1 and 2 GHG emissions intensity compared to 2019
- 29% reduction in water withdrawal intensity compared to 2019
- Enabled over 5.5 million smiles in 2023, contributing to more than 16.8 million smiles since 2021
- Achieved total average gender pay parity across the global workforce
- 54% of global hires in 2023 were diverse
- Hosted over 9,200 educational courses for customers in over 80 countries
- Achieved a top decile injury and illness prevention rate of 0.17
The company remains committed to its goal of Net Zero in Scope 1-3 carbon emissions by 2050 and continues to drive sustainable change within the dental industry through partnerships and initiatives.
Dentsply Sirona (Nasdaq: XRAY) has announced an upcoming investor conference call and live webcast scheduled for Thursday, November 7, 2024, at 8:30 am ET. The purpose of this event is to review the company's third quarter financial results.
Key details include:
- A presentation related to the call will be available on the Investors section of Dentsply Sirona's website.
- Investors can access the live webcast through the company's investor relations webpage.
- Those planning to participate in the call are required to register through a provided link.
- A webcast replay of the conference call will be made available on the company's website after the event.
This announcement demonstrates Dentsply Sirona's commitment to transparency and shareholder communication regarding its financial performance.
Dentsply Sirona (Nasdaq: XRAY) has introduced Primescan 2, a cloud-native intraoral scanning solution powered by DS Core. This wireless scanner can operate on any internet-connected device, offering improved workflow efficiency and extended treatment capabilities compared to previous models. Key benefits include:
- Hardware-independence: Works on any device with an internet browser
- Versatility: Wireless and portable
- Simple handling: Sleeker design with narrower tip
- Fast workflow: Full arch scan in less than 1 minute
- Cloud storage: Reduces need for additional scan storage costs
- Always up-to-date: Automatic software updates via DS Core
Primescan 2 aims to enhance patient experience, support practice growth, and deliver simplicity, efficiency, and versatility to dental professionals.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in two upcoming investor conferences. The company will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 9:15 am ET, and the Baird Global Healthcare Conference on September 10, 2024, at 9:40 am ET.
Investors and other interested parties can access live audio webcasts and audio webcast replays of these presentations through the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. This participation in major healthcare conferences demonstrates Dentsply Sirona's commitment to engaging with investors and sharing insights about the company's performance and outlook in the dental industry.
Dentsply Sirona (Nasdaq: XRAY) has announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to take an executive position at another public company. The dental equipment manufacturer has initiated a search for a new CFO with the help of a leading executive search firm.
CEO Simon Campion praised Coleman's contributions over the past two years, highlighting his role in implementing the company's business transformation plan, initiating ERP modernization efforts, and supporting Employee Resource Groups. Coleman expressed pride in his accomplishments at Dentsply Sirona and confidence in the company's future success under its current leadership team.
Dentsply Sirona (NASDAQ: XRAY) reported Q2 2024 results with net sales of $984 million, down 4.2% year-over-year. The company experienced a net loss of $4 million or ($0.02) per share, compared to net income of $86 million in Q2 2023. Adjusted EPS was $0.49, down from $0.51 in the previous year.
Key highlights include:
- Organic sales decreased by 2.3%
- GAAP gross margin of 51.9%
- Adjusted EBITDA margin of 17.5%
- $150 million in share repurchases during Q2
Dentsply Sirona revised its FY24 outlook, now expecting organic sales to be down 1% to flat, and adjusted EPS between $1.96 and $2.02. The company also announced a second phase of transformation, aiming to reduce annualized operating expenses by $80 to $100 million over 12 to 18 months.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on July 31, 2024, at 8:30 am ET to discuss its second-quarter financial results. The presentation will be accessible on the company's investor site. Interested participants can register for the call via a provided link, and a replay will be available post-event.
Dentsply Sirona (Nasdaq: XRAY) has canceled its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions.
The company was initially scheduled to take part on June 13, 2024, at 8:00 am ET.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in two upcoming investor conferences. The company will present at the William Blair 44th Annual Growth Stock Conference on June 5, 2024, at 9:20 am CT and the Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, at 8:00 am ET. Interested parties can access live and replay webcasts via the Dentsply Sirona investor website.
Dentsply Sirona, trading under the Nasdaq symbol XRAY, announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock.
This equates to an annual rate of $0.64 per share. The dividend is scheduled to be paid on July 12, 2024, to shareholders who are on record as of June 28, 2024.
FAQ
What is the current stock price of Dentsply Sirona (XRAY)?
What is the market cap of Dentsply Sirona (XRAY)?
